1. Home
  2. CTSO vs VTSI Comparison

CTSO vs VTSI Comparison

Compare CTSO & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • VTSI
  • Stock Information
  • Founded
  • CTSO 1997
  • VTSI 1993
  • Country
  • CTSO United States
  • VTSI United States
  • Employees
  • CTSO N/A
  • VTSI N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • CTSO Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • CTSO Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • CTSO 68.2M
  • VTSI 67.3M
  • IPO Year
  • CTSO N/A
  • VTSI N/A
  • Fundamental
  • Price
  • CTSO $0.84
  • VTSI $5.84
  • Analyst Decision
  • CTSO Buy
  • VTSI Strong Buy
  • Analyst Count
  • CTSO 2
  • VTSI 1
  • Target Price
  • CTSO $5.50
  • VTSI $7.00
  • AVG Volume (30 Days)
  • CTSO 149.4K
  • VTSI 119.8K
  • Earning Date
  • CTSO 05-14-2025
  • VTSI 05-12-2025
  • Dividend Yield
  • CTSO N/A
  • VTSI N/A
  • EPS Growth
  • CTSO N/A
  • VTSI N/A
  • EPS
  • CTSO N/A
  • VTSI 0.19
  • Revenue
  • CTSO $35,332,238.00
  • VTSI $26,164,645.00
  • Revenue This Year
  • CTSO $18.72
  • VTSI $9.92
  • Revenue Next Year
  • CTSO $19.75
  • VTSI $16.54
  • P/E Ratio
  • CTSO N/A
  • VTSI $30.76
  • Revenue Growth
  • CTSO 15.37
  • VTSI N/A
  • 52 Week Low
  • CTSO $0.70
  • VTSI $3.57
  • 52 Week High
  • CTSO $1.61
  • VTSI $9.85
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 41.67
  • VTSI 61.89
  • Support Level
  • CTSO $0.81
  • VTSI $5.02
  • Resistance Level
  • CTSO $0.90
  • VTSI $5.86
  • Average True Range (ATR)
  • CTSO 0.06
  • VTSI 0.46
  • MACD
  • CTSO 0.00
  • VTSI 0.02
  • Stochastic Oscillator
  • CTSO 32.77
  • VTSI 57.18

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: